Why the study?
Does inhaled sevoflurane improve recovery time and haemodynamic stability compared to intravenous propofol in patients undergoing elective cardioversion?
Does inhaled sevoflurane improve recovery time and haemodynamic stability compared to intravenous propofol in patients undergoing elective cardioversion?
Sevoflurane provides faster recovery and better haemodynamic stability than propofol for elective cardioversion anaesthesia.
May support sevoflurane for faster cardioversion recovery; leaves open confirmation in randomized trials before practice change.
This study compared the induction time, haemodynamic changes, recovery characteristics and patient satisfaction for sevoflurane and propofol when used as the main anaesthetic agents for cardioversion. Sixty-one unpremedicated patients scheduled for elective cardioversion were anaesthetised with either inhaled sevoflurane 8% or an intravenous propofol target-controlled infusion set at 6 microg.ml(-1). There was no significant difference in induction time between the two groups: mean (SD) = 90.1(40) s in the sevoflurane group vs. 83.7(35) s in the propofol group. Mean (SD) time to recovery was significantly shorter in the sevoflurane group than in the propofol group: 318 (127) s vs.738 (355) s, respectively, p < 0.001. At recovery, the patients in the propofol group had significantly lower systolic and diastolic blood pressures than those in the sevoflurane group, p < 0.001. The incidence of complications was low in both groups, with similar patient satisfaction expressed after the procedure. We conclude that sevoflurane is a suitable choice for anaesthesia for cardioversion and may provide greater haemodynamic stability than a target-controlled infusion of propofol.
No takes yet. Share an insight, caveat, or question.
Balachandran et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: